Trials / Recruiting
RecruitingNCT07000916
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults. Optimization of Clinical Response, Remission, Quality of Life and Analysis of Prognostic Markers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 2 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Population: Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS). Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. These 5 cohorts will be subject to standardized clinical monitoring.
Detailed description
This study is proposed by the Rheumatology and Pediatrics departments of the 3 French-speaking Universities. The first objective will be to include a progressive number of new young patients (≤ 50 years) in order to optimize and standardize care and clinical response objectives. The number of 25% of new incident cases will be sought with an increase of 20% each year during the 5 to 10 years of this project. Population: JIA, RA/UA, SLE, dSS (American Congres of Rheumatology criteria). Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. These 5 cohorts will be subject to standardized clinical monitoring and specific objectives that will make it possible to analyze the number of patients with a good control of the disease and/or a clinical remission, defined according to the international criteria.
Conditions
- Juvenile Idiopathic Arthritis
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Systemic Lupus Erythematosus
- Diffuse Systemic Sclerosis
- Seronegative Arthritis
Timeline
- Start date
- 2013-09-11
- Primary completion
- 2028-03-31
- Completion
- 2028-03-31
- First posted
- 2025-06-03
- Last updated
- 2025-06-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07000916. Inclusion in this directory is not an endorsement.